Cell Cycle Analysis of p26-BCL-2 Protein Levels in Proliferating Lymphoma and Leukemia Cell Lines

Cancer Research

Volumn 52, Issue 10, 1992, Pages 2802-2805

  Reed, John C ^a   Tanaka, Shigeki ^a   Cuddy, Michael ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLINE; HYDROXYUREA; MEMBRANE PROTEIN; NOCODAZOLE; QUERCETIN;

ARTICLE; CELL CYCLE PHASE; CELL GROWTH; CENTRIFUGATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; LYMPHOMA; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DETERMINATION;

CELL CYCLE; CENTRIFUGATION; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, PRE-B-CELL; LYMPHOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0026753034     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. Involvement of the bcl-2 gene in human follicular lymphomas. Science (Washington DC), 228: 1440-1443,1985.
2. Reed, J. C., Tsujimoto, Y., Epstein, S. F., Cuddy, M., Slabiak, T., Nowell, P. C., and Croce, C. M. Regulation of bcl-2 gene expression in lymphoid cell lines containing normal #18 or t(14;18) chromosomes. Oncogene Res., 4: 271-282,1989.
3. Taub, R., Kirsch, I., Morton, O., Lenoir, G., Swan, D. Tronick, S., Aaronson, S., and Leder, P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmcytoma cells. Proc. Natl. Acad. Sci. USA, 79:7837-7841,1982.
4. Reed, J. C., Tsujimoto, Y., Alpers, J. D., Croce, C. M., and Nowell, P. C. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science (Washington DC), 236:1295-1299,1987.
5. Graninger, W., Seto, M., Boutain, B., Goldman, P., and Korsmeyer, S. Expression of bcl-2 and bcl-2-Ig fusion transcripts in normal and neoplastic cells. J. Clin. Invest., 80:1512-1515,1987.
6. Makover, D., Cuddy, M., Yum, S., Bradley, K., Alpers, J., Sukhatme, V., and Reed, J. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell lukemia line JURKAT. Oncogene, 6:455-460,1991.
7. Vaux, D., Cory, S., and Adams, J. BCL2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335:440-442,1988.
8. McDonnell, T., Deane, N., Platt, F., Nunez, G., Jaeger, U., McKearn, J., and Korsmeyer, S. BCL2-immunoglobulin transgenic mice demonstrate ex-tended B cell survival and follicular lymphoproliferation. Cell, 57: 79-88, 1989.
9. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348:334-336,1990.
10. Reed, J. C., Cuddy, M., Slabiak, T., Croce, C. M., and Nowell, P. C. Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature (Lond.), 336:259-261,1988.
11. Reed, J. C., Haldar, S., Croce, C. M., and Cuddy, M. P. Complementation by BCL2 and C-HA-/2/4S oncogenes in malignant transformation of rat embryo fibroblasts. Mol. Cell. Biol., 10:4370-4374,1990.
12. Reed, J. C., Talwar, H. S., Cuddy, M., Baffy, G., Williamson, J., Rapp, U. R., and Fisher, G. J. Mitochondrial protein p26 BCL2 reduces growth factor requirements of NIH3T3 fibroblasts. Exp. Cell. Res., 195:277-283,1991.
13. Reed, J. C., Stein, C., Subasinghe, C., Haldar, S., Croce, C. M., Yum, S., and Cohen, J. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res., 50: 6565-6570, 1990.
14. Sanderson, R. J., Buch, K. F., Palmer, N. F., and Brenman, J. Design principles of a counterflow centrifugation cell separation chamber. Anal. Biochem., 77:615-622,1976.
15. Thompson, C. B., Ryan, J. J., Sieckmann, D. G., Finkelman, F. D., Mond, J. J., and Scher, 1. A method for size separation of murine spleen cells using counterflow centrifugation. J. Immunol. Methods, 63:299-307,1983.
16. Reed, J. C., Yum, S., Cuddy, M. P., Turner, B. C., and Rapp, U. R. Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenes. Cell Growth Diff., 2:235-243,1991.
17. Reed, J. C., Meister, L., Tanaka, S., Cuddy, M., Yum, S., Geyer, C., and Pleasure, D. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res., 51: 6529-6538, 1991.
18. Ogata, K., Kurki, P., Celis, J. E., Nakamura, R. M., and Tan, E. M. Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp. Cell Res., 168:475-486,1987.
19. Giordano, A., Whyte, P., Harlow, E., Franza, B. R., Jr., and Draetta, G. A 60 kd cdc2-associated polypeptide complexes with the El A proteins in adenovirus-infected cells. Cell, 58:981-990,1989.
20. Gurfinkel, N., Unger, T., Givo, D., and Mushinski, J. F. Expression of the bcl-2 gene in mouse B lymphocytic cell lines is differentiation stage specific. Eur. J. Immunol., 17:567-570,1987.
21. Gauwerky, C. E., Hoxie, J., Nowell, P. C., and Croce, C. M. Pre-B-cell leukemia with a t(8;14) and a t(14: 18) translocation is preceded by follicular lymphoma. Oncogene, 2:431-435,1988.
22. Morris, G. F., and Mathews, M. B. Regulation of proliferating cell nuclear antigen during the cell cycle. J. Biol. Chem., 264:13856-13864,1989.
23. Adams, R. L., and Lindsay, J. G. Hydroxyurea: reversal of inhibition and use as a cell-synchronizing agent. J. Biol. Chem., 242:1314-1317,1967.
24. Almendral, J. M., Huebsch, D., Blundell, P. A., Macdonald-Brano, H., and Bravo, R. Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins. Proc. Natl. Acad. Sci. USA, 84:1575-1579, 1987.
25. Bravo, R. Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp. Cell Res., 163:287-293,1986.
26. De Brabander, M. J., Van de Viere, R. M. L., Aerts, F. E. M., Borgers, M., and Janssen, P. A. J. The effects of methyl [5-(2-thienyl-carbonyl)-lH-benzimidazol-2-yl] carbamate (R 17934: NSC 238159), a new synthetic antitumoral drug interfering with microtubules on mammalian cells cultured in vitro. Cancer Res., 36:905-916,1976.
27. Draetta, G., and Beach, D. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell, 54:17-26, 1988.
28. Tsujimoto, Y., Ikegaki, N., and Croce, C. M. Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene, 2:3-7,1987.
29. Thompson, C. B., Challoner, P. B., Neiman, P. E., and Groudine, M. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature (Lond.), 314:363-366,1985.
30. Hann, S. R., Thompson, C. B., and Eisenman, R. N. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature (Lond.), 314:366-369,1985.
31. Bravo, R., and Macdonald-Bravo, H. Changes in nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication. EMBO J., 4. 655-661,1985.
32. Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., and Korsmeyer, S. J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88:6961-6965,1991.
33. Pezzella, F., Tse, A. G. D., Cordell, J. L., Pulford, K. A. F., Gatter, K. C., and Mason, D. Y. Expression of the bcl-2 oncogene protein is not specific for the 14: 18 chromosomal translocation. Am. J. Pathol., 137: 225-232, 1990.